Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.1%

231 terminated/withdrawn out of 1152 trials

Success Rate

72.9%

-13.6% vs industry average

Late-Stage Pipeline

15%

170 trials in Phase 3/4

Results Transparency

56%

346 of 621 completed trials have results

Key Signals

175 recruiting346 with results121 terminated110 withdrawn

Enrollment Performance

Analytics

N/A
440(48.6%)
Phase 2
163(18.0%)
Phase 4
126(13.9%)
Phase 1
101(11.2%)
Phase 3
44(4.9%)
Early Phase 1
31(3.4%)
905Total
N/A(440)
Phase 2(163)
Phase 4(126)
Phase 1(101)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1152)

Showing 20 of 1152 trials
NCT05564715Not ApplicableCompleted

Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment

Role: lead

NCT05625191Recruiting

Patients With and Without Phonotrauma

Role: lead

NCT04156997Active Not Recruiting

Extreme Lipids Repository

Role: lead

NCT03508752Phase 1Active Not Recruiting

Neurocognitive Decline in Patients With Brain Metastases

Role: lead

NCT06480227Not ApplicableRecruiting

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Role: collaborator

NCT07041775Not ApplicableRecruiting

MINT Conditioning to Improve Gait

Role: collaborator

NCT04583878Active Not Recruiting

FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease

Role: lead

NCT04502550Terminated

Brain Networks and Consciousness

Role: lead

NCT04098666Phase 2Active Not Recruiting

Metformin in Alzheimer's Dementia Prevention

Role: collaborator

NCT07183644Not ApplicableRecruiting

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

Role: lead

NCT03525262Phase 2Active Not Recruiting

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

Role: lead

NCT05489523Phase 4Active Not Recruiting

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Role: lead

NCT04446442Not ApplicableRecruiting

Cerebellar tDCS in Children With Autism Spectrum Disorder

Role: lead

NCT07569250Not ApplicableNot Yet Recruiting

Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization

Role: collaborator

NCT07383714Not ApplicableRecruiting

Nudging Parental Actions for Youth Suicide Prevention

Role: lead

NCT06811363Enrolling By Invitation

Contribution of Bone to Urine Citrate

Role: lead

NCT02400190Not ApplicableActive Not Recruiting

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

Role: collaborator

NCT03565913Phase 2Active Not Recruiting

Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V

Role: lead

NCT04068844Not ApplicableCompleted

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Role: lead

NCT07622927Recruiting

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

Role: lead